Solcoseryl Eye Gel

Solcoseryl Eye Gel

Manufacturer:

A. Menarini

Distributor:

Zuellig Pharma

Marketer:

A. Menarini
Full Prescribing Info
Contents
Protein-free dialysate.
Description
Protein-free dialysate from calves' blood, chemically and biologically standardised - 8.3 mg/g (calculated as dry mass).
Tube containing eye gel, in a box.
Action
Pharmacology: Pharmacokinetics: SOLCOSERYL is a protein-free haemodialysate that is obtained from whole calf blood in a process of dialysis and ultrafiltration. It contains a great number of low molecular weight components.
SOLCOSERYL intensifies the regeneration of cells that are reversibly damaged due to deficiency of oxygen or nutrients, which results in acceleration of renewal of tissues.
The action of SOLCOSERYL Eye-Gel consists in faster healing of injuries of the cornea, due to improved regeneration of the epithelium. This subsequently leads to scars of the cornea becoming smaller or even absent.
SOLCOSERYL Eye-Gel is especially suitable for the treatment of corneal injuries as an adjuvant drug, since it improves regeneration of tissues and reduces the risk of cicatrization.
Indications/Uses
Pathological conditions of the cornea: lesions caused by foreign bodies; cauterisations caused by acids or alkalies; lesions due to wearing contact lenses; filamentous keratitis; ulcerations of the cornea caused by bacteria, viruses, fungi and trophic disorders; degenerative and dystrophic keratitis.
For disorders and injuries of the eye.
Dosage/Direction for Use
Unless otherwise prescribed, apply 1 drop to the conjunctival sac 3-4 times a day.
Do not touch the tip of the tube during the administration.
Close the tube immediately after the administration.
Do not touch the tip of the tube with the fingers.
Do not use longer than 4 weeks after opening the tube.
Contraindications
SOLCOSERYL Eye-Gel contains benzalkonium chloride as preservative. The medicinal product should not be used in case of diagnosed hypersensitivity to previously mentioned substance or to any other ingredient.
Special Precautions
Animal reproductive studies have revealed no risk, however the preparation should be used cautiously during pregnancy. No controlled studies have been performed in pregnant women. There are no objections to use of the preparation SOLCOSERYL Eye-Gel during breast-feeding. Contact the physician in case of any doubts regarding use of the preparation.
Influence of the medicinal product on the ability to drive mechanical vehicles, operate machines and on the psycho-physical skills: After the administration, the vision may be temporarily blurred. For a period of 20 minutes after the administration of the preparation do not drive cars or operate machines.
Use In Pregnancy & Lactation
Animal reproductive studies have revealed no risk, however the preparation should be used cautiously during pregnancy. No controlled studies have been performed in pregnant women. There are no objections to use of the preparation SOLCOSERYL Eye-Gel during breast-feeding. Contact the physician in case of any doubts regarding use of the preparation.
Adverse Reactions
Brief stinging may occur after the administration, but the preparation may be still applied. Allergic reactions may occur after repeated application.
Drug Interactions
Natural metabolites (pyrimidine and purine bases or their derivatives) that are contained in the preparation may diminish the action of some local antiviral medicines, e.g. of Acyclovir.
Storage
Store below 25°C. Protect from light.
Shelf-Life:
3 years.
ATC Classification
S01XA - Other ophthalmologicals ; Used in ophthalmic preparations.
Presentation/Packing
Eye gel 8.3 mg/g x 5 g.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in